Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Blocking of sodium and potassium ion-dependent adenosine triphosphatase-a1 with ouabain and vanadate suppresses cell-cell fusion during RANKL-mediated osteoclastogenesis.

Makihira S, Nikawa H, Kajiya M, Kawai T, Mine Y, Kosaka E, Silva MJ, Tobiume K, Terada Y. Blocking of sodium and potassium ion-dependent adenosine triphosphatase-a1 with ouabain and vanadate suppresses cell-cell fusion during RANKL-mediated osteoclastogenesis. Eur J Pharmacol. 2011 Nov 30; 670(2-3):409-18.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.